欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Cardiovascular Disease

货号 产品名 CAS号 信息
CSN12447 Fondaparinux sodium 114870-03-0 Fondaparinux sodium is a pentasaccharide inhibitor of antithrombin-dependent factor Xa (IC50 = 40 nM). It can bind to antithrombin III.
CSN12445 Enalapril Maleate 76095-16-4 Enalapril maleate is a prodrug ACE inhibitor, which can be rapidly metabolized in the liver to enalaprilat.
CSN12515 Losartan potassium 124750-99-8 Losartan Potassium is the potassium salt form of Losartan, which is a compeitive AT1 receptor inhibitor with IC50 value of 20 nM.
CSN12536 (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid 137862-53-4 Valsartan is a selective angiotensin II AT1 receptor antagonist with elimination half-life‎ of ‎6 hours.
CSN12537 Irbesartan 138402-11-6 Irbesartan is a selective and competitive nonpeptide angiotensin II antagonist with antihypertensive activity.
CSN12544 Candesartan 139481-59-7 Candesartan is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.
CSN12551 Olmesartan medoxomil 144689-63-4 Olmesartan Medoxomil is a synthetic imidazole-derived angiotensin II receptor antagonist, acting as a prodrug with an antihypertensive property.
CSN12552 Telmisartan 144701-48-4 Telmisartan is an angiotensin II receptor antagonist with Ki value of 3.7nM, used in the management of hypertension with elimination half-life‎ of ‎24 hours.
CSN12553 Candesartan cilexetil 145040-37-5 Candesartan Cilexetil is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.
CSN12575 Ezetimibe 163222-33-1 Ezetimibe is a cholesterol-absorption inhibitor, reduces levels of low-density lipoprotein (LDL) cholesterol when added to statin treatment. It's also a Niemann-Pick C1-like1 (NPC1L1) inhibitor and Nrf2 activator.
CSN12705 Azilsartan medoxomil 863031-21-4 Azilsartan Medoxomil is an orally available angiotensin II type 1 (AT1) receptor antagonist with IC50 value of 2.6 nM.
CSN12720 Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate 211915-06-9 Dabigatran etexilate, the active prodrug of dabigatran, is a selective inhibitor of thrombin with Ki of 4.5 nM.
CSN12758 (R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride 364782-34-3 Cinacalcet HCl is an orally active calcimimetic compound and represents a class of compounds for the treatment of hyperparathyroidism.
CSN12828 Bardoxolone methyl 218600-53-4 Bardoxolone methyl is an IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities. It is also a potent Nrf2 activator and nuclear factor-κB (NF-κB) activator.
CSN12830 BGP-15 66611-37-8 BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.
CSN12961 Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate 872728-81-9 Dabigatran etexilate mesylate inhibits thrombin with Ki value of 4.5 nM. It is the prodrug of dabigatran.
CSN12970 Vernakalant HCl 748810-28-8 Vernakalant HCl prolongs repolarization by blocking atrial potassium channels, it's a class III antiarrhythmics.
CSN12974 Sitaxsentan sodium 210421-74-2 Sitaxsentan sodium has selectory antagonism of endothelin A (ETA) receptor with the IC50 and Ki value of 1.4 nM and 0.43 nM respectively.
CSN12647 3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide 364-98-7 Diazoxide is an ATP-sensitive potassium channel activator which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions. and can be used to treat hyperinsulinism.
CSN12549 1-Benzhydryl-4-cinnamylpiperazine 298-57-7 Cinnarizine, an antihistamine, can block calcium channel and promote cerebral blood flow. It is used to treat post-trauma cerebral symptoms and cerebral arteriosclerosis.
CSN12923 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one 73963-72-1 Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake.
CSN12942 Doxazosin mesylate 77883-43-3 Doxazosin mesylate is a selective α1-adrenergic receptor blocker, used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH).
CSN12869 Nicorandil 65141-46-0 Nicorandil is a potassium channel activator, and stimulates guanylate cyclase to increase formation of cyclic GMP (cGMP).
CSN12981 Quinapril HCl 82586-55-8 Quinapril HCl is a prodrug-form ACE inhibitor with a Ki of 20 μM, usd for treatment for hypertension and congestive heart failure.
CSN12736 Phenoxybenzamine HCl 63-92-3 Phenoxybenzamine HCl is a non-selective irreversible dibenzamine α adrenergic antagonist with antihypertensive and vasodilatory properties.
CSN12852 Barnidipine HCl 104757-53-1 Barnidipine HCl is a calcium-channel blocker.
CSN12478 Nateglinide 105816-04-4 Nateglinide is an insulin secretagog agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).
CSN12933 (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid 81093-37-0 Pravastatin is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.
CSN12369 Betrixaban 330942-05-7 Betrixaban is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM (inhibition of Factor 10a).
CSN12947 Fluvastatin 93957-54-1 Fluvastatin inhibits HMG-CoA reductase activity with IC50 of 8 nM.
CSN12339 NS-1619 153587-01-0 NS-1619 is a selective large conductance Ca2+-activated K+-channel activator.
CSN12960 Clevidipine 167221-71-8 Clevidipine is a short-acting dihydropyridine calcium channel antagonist with IC50 of 7.1 nM, it's under development for treatment of perioperative hypertension.
CSN12451 Dobutamine HCl 49745-95-1 Dobutamine HCl is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock.
CSN12596 Amiodarone HCl 19774-82-4 Amiodarone HCl is an antiarrhythmic drug for inhibition of ATP-sensitive potassium channel with IC50 of 19.1 μM.
CSN12884 (-)-Sparteine sulfate pentahydrate 6160-12-9 (-)-Sparteine sulfate is a class 1a antiarrhythmic agent and a sodium channel blocker.
CSN12975 Sitaxsentan 184036-34-8 Sitaxsentan is a selective endothelin A (ETA) receptor antagonist.
CSN12653 Nitrendipine 39562-70-4 Nitrendipine is a dihydropyridine calcium channel blocker with an IC50 of 95 nM.
CSN12356 Anacetrapib 875446-37-0 Anacetrapib is a potent, selective, reversible rhCETP and mutant CETP (C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure.
CSN12734 Argatroban 74863-84-6 Argatroban is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM, used as an anticoagulant.
CSN12826 (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol 274693-27-5 Ticagrelor is a reversibly and oral active P2Y12 receptor antagonist with Ki of 2 nM, also inhibits CYP2C9 and midazolam 4-hydroxylation with IC50 of 10.5 μM and 8.2 μM respectively.
CSN12844 2-(3-(3-((2-Chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)amino)propoxy)phenyl)acetic acid hydrochloride 405911-17-3 GW3965 HCl is a selective and non-steroidal LXR agonist with EC50 values of 190 and 30 nM for hLXRα and hLXRβ, respectively.
CSN12872 Avosentan 290815-26-8 Avosentan is a potent, selective endothelin receptor (ETA receptor) antagonist.
CSN12874 3-Isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 66085-59-4 Nimodipine is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity. Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.
CSN12900 Edoxaban 480449-70-5 Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
<< PREV 2 3 4 5 6 7 8 9 10 NEXT >>
联系
我们